Cargando…
Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial
PURPOSE: Some variations in the sequence of methionine synthase reductase (MTRR) gene can increase the risk of various cancers such as prostate cancer. The aim of this study was to investigate the association between prostate cancer and the MTRR A66G and C524T gene single nucleotide polymorphisms (S...
Autor principal: | Basir, Atefeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857893/ https://www.ncbi.nlm.nih.gov/pubmed/31127906 http://dx.doi.org/10.31557/APJCP.2019.20.5.1445 |
Ejemplares similares
-
Analysis of methionine synthase reductase polymorphism (A66G) in Indian Muslim population
por: Rai, Vandana, et al.
Publicado: (2013) -
The Polymorphisms in Methylenetetrahydrofolate Reductase, Methionine Synthase, Methionine Synthase Reductase, and the Risk of Colorectal Cancer
por: Zhou, Daijun, et al.
Publicado: (2012) -
Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Pabalan, Noel, et al.
Publicado: (2015) -
Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients
por: Elderdery, Abozer Y., et al.
Publicado: (2022) -
A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer
por: Zhang, Xiaosong, et al.
Publicado: (2018)